INDICATIONS AND USAGE
Omlonti (omidenepag isopropyl ophthalmic solution) 0.002%, is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
IMPORTANT SAFETY INFORMATION
Brown color, or increased brown color, of the iris can occur, which may be permanent. Omlonti may also cause eyelash changes. Eyelash changes are usually reversible upon discontinuation of treatment. see more

Glaucoma overview

Glaucoma is a group of eye diseases that damage the optic nerve, often due to increased intraocular pressure, which is the pressure inside the eye. This pressure buildup occurs when the fluid in the eye, called aqueous humor, cannot drain properly. Over time, the elevated pressure damages the delicate nerve fibers of the optic nerve, which transmits visual information from the retina to the brain. This damage initially affects peripheral vision and, if left untreated, can progress to involve central vision, eventually leading to irreversible blindness. Treating glaucoma is crucial because the damage to the optic nerve is permanent, and vision loss cannot be recovered. Early detection and consistent treatment, can effectively lower eye pressure and slow down or prevent further damage to the optic nerve, thus preserving a person’s sight.